https://www.selleckchem.com/products/i-191.html
In the warfarin group two patients withdrew and in the apixaban group one patient died. Thrombus completely resolved in 14 of 15 patients in the warfarin group and in 16 of 17 in the apixaban group ((P=NS, P=0.026 for non-inferiority). Two patients had major bleeding in the warfarin group while no major bleeding events were recorded in the apixaban group. There was one stroke in the warfarin group and one death in the apixaban group. Our results suggest that apixaban is non-inferior to warfarin for treatment of patients with LV thrombus a
Like
Comment
Share
